Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Monomer contains oxygen
Reexamination Certificate
2004-08-23
2010-02-23
Fubara, Blessing M (Department: 1618)
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Monomer contains oxygen
C424S078010
Reexamination Certificate
active
07666398
ABSTRACT:
Polyanhydrides which link low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol group within their structure into polymeric drug delivery systems are provided. Also provided are methods of producing polymeric drug delivery systems via these polyanhydride linkers as well as methods of administering low molecular weight drugs to a host via the polymeric drug delivery systems.
REFERENCES:
patent: 4062855 (1977-12-01), Allan et al.
patent: 4126445 (1978-11-01), Allan et al.
patent: 4684620 (1987-08-01), Hruby et al.
patent: 4757128 (1988-07-01), Domb et al.
patent: 4792598 (1988-12-01), Ziegast
patent: 4857311 (1989-08-01), Domb et al.
patent: 4868274 (1989-09-01), Gupta et al.
patent: 4886870 (1989-12-01), D'Amore et al.
patent: 4891225 (1990-01-01), Langer et al.
patent: 4906474 (1990-03-01), Langer et al.
patent: 4997904 (1991-03-01), Domb
patent: 4999417 (1991-03-01), Domb
patent: 5082925 (1992-01-01), Shalaby et al.
patent: 5175235 (1992-12-01), Domb et al.
patent: 5259968 (1993-11-01), Emert et al.
patent: 5264540 (1993-11-01), Cooper et al.
patent: 5498729 (1996-03-01), Domb
patent: 5514764 (1996-05-01), Frechet et al.
patent: 5545409 (1996-08-01), Laurencin et al.
patent: 5629009 (1997-05-01), Laurencin et al.
patent: 5902599 (1999-05-01), Anseth et al.
patent: 5942252 (1999-08-01), Tice et al.
patent: 6071530 (2000-06-01), Polson et al.
patent: 6468519 (2002-10-01), Uhrich
patent: 6486214 (2002-11-01), Uhrich
patent: 6613807 (2003-09-01), Uhrich
patent: 6685928 (2004-02-01), Uhrich et al.
patent: 6689350 (2004-02-01), Uhrich
patent: 288311 (1991-03-01), None
patent: 288387 (1991-03-01), None
patent: 0246341 (1987-11-01), None
patent: WO 91/09831 (1991-07-01), None
patent: WO 97/39738 (1997-10-01), None
patent: WO 98/36013 (1998-08-01), None
patent: WO 99/12990 (1999-03-01), None
patent: WO 99/29885 (1999-06-01), None
Erdmann et al. ((“Polymeric Prodrugs: Novel Polymers with Bioactive Components,” in tailored polymeric materials for controlled delivery systems, I. McCulloch, et al. eds., ACS Symposium series 709, American Chemical Society: Washington, D.C., pp. 83-91, 1998).
Erdmann et al. (“Polymeric Prodrugs: Novel Polymers for Delivery of Salicylic acid,” in Annals of Biomedical Engineering, 26, Suppl. 10, Abstract No. PB. 26, Annual Fall Meeting, p. S-124, 1998).
Erdmann et al. (“Polymeric Salicylic acid: in Vitro and in Vivo Degradation,” Polymer Preprints, 39 (2), pp. 224 and 225, 1998).
Anastasiou, T.J. et al., “Novel Polyanhydrides with Enhanced Thermal and Solubility Properties”,Macromolecules. 33(17), pp. 6217-6221, (2000).
Anastasiou, T.J., et al., Synthesis of Novel, Degradable Polyanhydrides Containing Para-Aminosalicyclic Acid as Drug Delivery Devices for Tuberculosis Treatment,Polymer Preprints, 41, (2), pp. 1366-1367, (Aug. 2000).
Attawia, M.A., et al., “Biocompatibility Testing of Poly(anhydride-co-imides) Containing Pyromellitylimidoalanine”,The 21st Annual Meeting of the Society for Biomaterials, Boston, Mass, p. 222, (1994).
Attawia, M.A., et al., “Cytotoxicity testinf of poly(anhydride-co-imides) for orthopedic applications”,Journal of Biomedical Materials Research, 29, pp. 1233-1240, (1995).
Attawia, M.A., et al., “In Vitro Bone Biocompatibility of Poly(anhydride-co-imides) Containing Pyromellitylimidoalanine”,Journal of Orthopedic Research, 14, pp. 445-454, (1996).
Attawia, M.A., et al., “Proliferation, Morphology, and Protein Expression by Osteoblasts Cultured on Poly(anhydride-co-imides)”,J. Biomed. Mater. Res.(Appl. Biomater.). 48, pp. 322-327, (1999).
Attawia, M.A., et al., “The Long Term Osteoblast Response to Poly(anhydride-co-imides): A New Degradable polymer for Use in Bone”,Proceedings of the Fifth World Biomaterials Congress, Toronto, Canada, p. 113, (1996).
Beaton, M.L., et al., “Synthesis of a novel poly(anhydride-ester)”,The Rutgers Scholar—An Electronic Bulletin of Undergraduate Research, 3, www.rutgersscholar.rutgers.edu/volum303/beatuhri/beatuhri.html, 7 p., (2001).
Bedell, C., et al., “Processing and Hydrolytic Degradation of Aromatic Ortho-Substituted Polyanhydrides”,Journal of Applied Polymer Science, 80, pp. 32-38, (2001).
Campo, C.J., et al., “Polyanhydrides: the effects of ring substitution changes on polymer properties”,Polymer Bulletin, 42 pp. 61-68, (1999).
Chafi, N., et al., “Dosage form with salicyclic acid attached to a polyanhydride polymer dispersed in an Eudragit matrix”,International Journal of Pharmaceutics, vol. 52, pp. 203-211, (1989).
Conix, A., “Aromatic Polyanhydrides, a New Class of High Melting Fiber-Forming polymers”,Journal of Polymer Science,XXIX, pp. 343-353, (1958).
Conix, A., “New High-Melting Fibre-Forming Polymers”,Die Makromolekulare Chemi, XXIV, pp.76-78, (1957).
Conix., A., “Poly[1, 3-bis (p-carboxyphenoxy)—Propane anhydride]”,Macromolecular Synthesis, 2, pp. 95-99, (1996).
Domb, A.J., “Synthesis and Characterization of Biodegradable Aromatic Anhydride Copolymers”,Macromolecules, 25, pp. 12-17, (1992).
Dukovic, G., et al., “Novel degradable poly(anhydride-esters) for controlled drug release”,The Rutgers Scholar—An electronic Bulletin of Undergraduate Research, 1, http://rutgersscholar.rutgers.edu/volume01/uhriduko/uhriduko.html., 10 p., 1999.
Erdmann, L., et al., “Degradable poly(anhydride ester) implants: effects of localized salicyclic acid release on bone”,Biomaterials 21, pp. 2507-2512, (2000).
Erdmann, L., et al., “Chapter 5: Polymeric Produgs: Novel Polymers with Bioactive Components”,In: tailored polymeric Materials for Controlled Delivery Systems, I. McCulloch, et al., (Eds.) ACS Symposium Series 709, American Chemical Society: Washington, D.C., pp. 83-91, (1998).
Erdman, L., et al. “Polymer Prodrugs with Pharmaceutically Active Degradation Products”,Polymer Preprints, 38 (2), pp. 570-571, (Sep. 1997).
Erdmann, L., et al., “Polymeric Produgs: Novel Polymers for Delivery of Salicyclic Acid”,Annals of Biomedical Engineering, 26, Suppl. 10, Abstract No. PB. 26, Annual Fall Meeting, p. S-124, (1998).
Erdmann, L., et al., “Polymeric Salicyclic Acid: In Vitro and in Vivo Degradation”,Polymer Preprints, 39 (2), pp. 224-225, (Aug. 1998).
Erdmann., L.., et al., “Synthesis and Characterization of a Polymeric Prodrug”,Proceedings of the American Chemical Society Division of Polymeric Materials: Science and Engineering, 78, Abstract of Spring Meeting, Dallas, TX, pp. 194, (Apr. 1998).
Erdmann, L., et al., “Synthesis and degradation characteristics of salicyclic acid-derived poly(anhydride-esters”,Biomaterials, 21, pp. 1941-1946, (2000).
Giammona, G., “Polymeric Produgs alpha beta poly-hydroxyethyl-dl-aspartamide as macromolecular carrier for some non steroidal anti-inflammatory agents”,Abstract from database BIOSIS Online, Biosciences Information Service, Philadelphia, PA, original publication from international Journal of Pharmaceutics (Amsterdam), 1 p., (1989).
Gouin, S., et al., “New Polyanhydrides Made from a Bile Acid Dimer and Sebacic Acid: Synthesis, Characterization, and Degradation”,Macromolecules, 33, pp. 5379-5383, (2000).
Ibim, S., et al., “Controlled Release Based on Poly(anhydride-co-imides)”,Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 22 2 pgs., (1995).
Ibim, S.E., et al., “Preliminary in Vivo Report on the Osteocompatibility of Poly(anhydride-co-imides) Evaluated in a Tribal Model”,Appp. Biomater., 43(4), pp. 374-379 1998.
Ibim, S.M., et al., “Poly(anhydride-co-imides): in vivo biocompatibility in a rat model”,Biomaterials, 19, pp. 941-951, (1998).
Krogh-Jespersen, E., et al., “Synthesis of a Novel Aromatic polyanhydride Containing aminosalicyclic Acid”,Polymer preprints, 41 (1), pp. 10
Fubara Blessing M
Rutgers, the State University of New Jersey
Viksnins Harris & Padys PLLP
LandOfFree
Polyanhydride linkers for production of drug polymers and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyanhydride linkers for production of drug polymers and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyanhydride linkers for production of drug polymers and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4164456